Increasing expansion of e-Health apps and telemedicine industries is projected to provide long-term revenue potential for firms in the antihypertensive drugs marketRising production of angiotensin
Demand for compounding medication for personalized medical care of exotic companion animal's fuels growth in animal drug compounding marketRapid adoption of newer therapies to propel North America
Rise in investment in R&D by pharma and biotech companies for the development of effective drugs for acute radiation syndrome or ARS propels market growthIncrease in efforts by pharmaceutical
/PRNewswire/ According to a recent market intelligence report by TMR, the global animal drug compounding market is estimated to register a CAGR of 7.4% over.